Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013 - Summary - MDSpire

Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013

  • By

  • Zafer Tandoğdu

  • Ricardo Bartoletti

  • Tomasso Cai

  • Mete Çek

  • Magnus Grabe

  • Ekaterina Kulchavenya

  • Bela Köves

  • Vandana Menon

  • Kurt Naber

  • Tamara Perepanova

  • Peter Tenke

  • Björn Wullt

  • Truls Erik Bjerklund Johansen

  • Florian Wagenlehner

  • December 11, 2015

  • 0 min

Share

Objective:

To identify the relationship between clinical severity of urosepsis and the pathogen spectrum and resistance, and to evaluate the appropriateness of using HAUTIs as representatives of urosepsis, emphasizing the differences between the two.

Key Findings:
  • Urosepsis was diagnosed in 408 patients (25.4% of HAUTIs), with specific resistance rates for various antibiotics documented, highlighting significant multidrug resistance.
Interpretation:

The study highlights the need for tailored antibiotic treatment strategies in urosepsis due to the distinct pathogen spectrum and resistance profiles compared to HAUTIs, suggesting implications for clinical practice.

Limitations:
  • Data derived from a single day each year may not represent seasonal variations in infections, potentially skewing results.
  • The study did not include all antibiotics necessary for complete resistance classification, which may limit the comprehensiveness of resistance profiling.
Conclusion:

The findings underscore the importance of understanding urosepsis-specific pathogens and resistance patterns to improve clinical outcomes, suggesting a need for revised treatment protocols.

Original Source(s)

Related Content